Brian Millham - Apr 1, 2024 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and COO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Stock symbol
CRM
Transactions as of
Apr 1, 2024
Transactions value $
-$2,826,134
Form type
4
Date filed
4/2/2024, 04:17 PM
Previous filing
Mar 27, 2024
Next filing
Apr 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $4.56M +24.5K $186.51 24.5K Apr 1, 2024 Direct F1
transaction CRM Common Stock Sale -$4.04M -13.4K -54.85% $301.51 11K Apr 1, 2024 Direct F1, F2
transaction CRM Common Stock Sale -$2.43M -8.04K -72.83% $302.61 3K Apr 1, 2024 Direct F1, F3
transaction CRM Common Stock Sale -$910K -3K -100% $303.21 0 Apr 1, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -24.5K -25% $0.00 73.4K Apr 1, 2024 Common Stock 24.5K $186.51 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.
F2 Weighted average price. These shares were sold in multiple transactions at prices ranging from $301.1300 to $301.8800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $302.1300 to $303.1100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $303.1400 to $303.3100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Option vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.